Select Medical Holdings Corporation (SEM) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SEM Revenue Growth
Revenue Breakdown (FY 2025)
SEM's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
SEM Revenue Analysis (2014–2025)
As of May 7, 2026, Select Medical Holdings Corporation (SEM) generated trailing twelve-month (TTM) revenue of $5.52 billion, reflecting solid growth of +5.0% year-over-year. The most recent quarter (Q1 2026) recorded $1.42 billion in revenue, up 1.8% sequentially.
Looking at the longer-term picture, SEM's 5-year compound annual growth rate (CAGR) stands at -0.3%, indicating revenue contraction over this period. The company achieved its highest annual revenue of $6.66 billion in 2023.
Revenue diversification analysis shows SEM's business is primarily driven by Health Care, Patient Service, Non-Medicare (61%), Health Care, Patient Service, Medicare (29%), and Service, Other (10%). With over half of revenue concentrated in Health Care, Patient Service, Non-Medicare, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including ENSG (+19.2% YoY), ACHC (+6.8% YoY), and UHS (+10.4% YoY), SEM has underperformed the peer group in terms of revenue growth. Compare SEM vs ENSG →
SEM Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SEMCurrent | $5.5B | +5.0% | -0.3% | 6.1% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% | |
 ACHC | $3.3B | +6.8% | +9.7% | 11.7% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% | |
 SGRY | $3.3B | +5.4% | +12.2% | 11.8% | |
 HCA | $75.6B | +7.1% | +8.0% | 15.8% |
SEM Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.45B | +5.1% | $629.3M | 11.5% | $334.6M | 6.1% |
| 2024 | $5.19B | -22.2% | $633.6M | 12.2% | $268.3M | 5.2% |
| 2023 | $6.66B | +5.2% | $932.0M | 14.0% | $554.9M | 8.3% |
| 2022 | $6.33B | +2.1% | $733.4M | 11.6% | $403.3M | 6.4% |
| 2021 | $6.20B | +12.2% | $919.4M | 14.8% | $713.8M | 11.5% |
| 2020 | $5.53B | +1.4% | $821.3M | 14.8% | $567.7M | 10.3% |
| 2019 | $5.45B | +7.3% | $812.9M | 14.9% | $471.9M | 8.7% |
| 2018 | $5.08B | +14.3% | $740.2M | 14.6% | $417.3M | 8.2% |
| 2017 | $4.44B | +3.7% | $709.4M | 16.0% | $355.9M | 8.0% |
| 2016 | $4.29B | +14.5% | $621.2M | 14.5% | $299.8M | 7.0% |
See SEM's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SEM Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SEM vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSEM — Frequently Asked Questions
Quick answers to the most common questions about buying SEM stock.
Is SEM's revenue growth accelerating or slowing?
SEM revenue growth slowed to +5.0%, below the 5-year CAGR of -0.3%. TTM revenue is $5.5B. The deceleration marks a shift from historical growth rates.
What is SEM's long-term revenue growth rate?
Select Medical Holdings Corporation's 5-year revenue CAGR of -0.3% reflects the variable expansion pattern. Current YoY growth of +5.0% is near this long-term average.
How is SEM's revenue distributed by segment?
SEM reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.